Immunome CSO Michael Morin resigns to part-time Chief Scientist; salary cut to $60,000

Immunome Inc.

Michael Morin resigned as CSO and EVP effective Aug 1, 2021; now part-time Chief Scientist (~5 days/month).
Annual base salary reduced to $60,000; eligible for prorated 2021 bonus (target 40% of prior salary, 7 months).
Equity vesting continues unchanged under existing grant agreements.
Morin will report to Chief Development Officer and work primarily from home office.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Michael J. Morin

Chief Scientist

IMNM · Immunome Inc.

Effective: 2021-08-01
Filed: August 5, 2021, 7:59 PM ET

Dr. Morin resigned from his positions as Chief Scientific Officer and Executive Vice President of the Company. Pursuant to the Employment Agreement, Dr. Morin will be employed by the Company on a part-time basis as its Chief Scientist.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael J. Morin was appointed as Chief Scientist at Immunome Inc..

Action: appointed
Role: Chief Scientist

Exact text from the filing

Dr. Morin resigned from his positions as Chief Scientific Officer and Executive Vice President of the Company. Pursuant to the Employment Agreement, Dr. Morin will be employed by the Company on a part-time basis as its Chief Scientist.

View on SEC.gov

Immunome Inc. filing history →

Source: SEC EDGAR

accession 0001104659-21-100801

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.